Brief: Avadel Board Of Directors Declares Lundbeck Proposal A “Company Superior Proposal”
17/11/2025 10:47
Alkermes Plc ALKS.O: AVADEL BOARD OF DIRECTORS DECLARES LUNDBECK PROPOSAL A “COMPANY SUPERIOR PROPOSAL” AVADEL PHARMACEUTICALS: PURSUANT TO ALKERMES DEAL, CO & ALKERMES MAY NEGOTIATE POTENTIAL ADJUSTMENTS TO EXISTING TRANSACTION FOR 5 BUSINESS DAYS Source text: ID:nGNXbLZ1hS Further company coverage: ALKS.O
Recent news on H Lundbeck A/S
See all newsEurope Research Roundup: BAWAG Group, Enka Insaat, Partners Group Holding
Brief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Europe Research Roundup: BNP Paribas, Swedbank, Volkswagen
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Brief: H Lundbeck A/S Says Noted That Our Offer For Acquiring Avadel No Longer Is Considered Superior By Their Board, We Are Currently Considering Our Options